Abstract: A three-dimensional Bragg grating may include a single colloidal crystal that includes a plurality of repeated layers of material having different refractive indexes. A sample cell for producing a volume Bragg grating may include an internal shape that forms at least one capillary cell having a flat surface and rounded edges. A method of producing a three-dimensional Bragg grating may include: suspending insoluble particles in a host fluid to form a suspension; and exposing the suspension to a sustained microgravity environment.

Abstract: The present disclosure provides improved stripfilm based pharmaceutical products (e.g., for enhancing dissolution and bioavailability). More particularly, the present disclosure provides improved systems/methods for fabricating stripfilm based pharmaceutical products by utilizing higher viscosity film forming precursors and drying methods that accomplish improved/faster drying and provide improved/excellent content uniformity of active pharmaceutical agents in the stripfilm based pharmaceutical products. Exemplary systems/methods advantageously use high viscosity, bio-compatible polymeric precursors, (optional use of surface modified drug powders), and convective drying for fabrication of thin films loaded with nano and/or micro sized particles of poorly water-soluble active pharmaceutical ingredients (APIs) to achieve improved active content uniformity and very fast dissolution from poorly water soluble actives, while accomplishing fast drying during the fabrication process.

Abstract: A benchtop device flow setup for determining the effectiveness of magnetic treatment of feed water for reducing mineral scaling includes two similar branches, both equipped with a reverse osmosis membrane and a pump that operate in the transient regime at the same flow rate and transmembrane pressure. The flow setup is further fed with a solution at the same level of supersaturation measured in a stirred reactor, however, only one branch exposes the feed to a magnetic field.

Abstract: A benchtop device flow setup for determining the effectiveness of magnetic treatment of feed water for reducing mineral scaling includes two similar branches, both equipped with a reverse osmosis membrane and a pump that operate in the transient regime at the same flow rate and transmembrane pressure. The flow setup is further fed with a solution at the same level of supersaturation measured in a stirred reactor, however, only one branch exposes the feed to a magnetic field.

Abstract: The present disclosure provides improved stripfilm based pharmaceutical products (e.g., for enhancing dissolution and bioavailability). More particularly, the present disclosure provides improved systems/methods for fabricating stripfilm based pharmaceutical products by utilizing higher viscosity film forming precursors and drying methods that accomplish improved/faster drying and provide improved/excellent content uniformity of active pharmaceutical agents in the stripfilm based pharmaceutical products. Exemplary systems/methods advantageously use high viscosity, bio-compatible polymeric precursors, (optional use of surface modified drug powders), and convective drying for fabrication of thin films loaded with nano and/or micro sized particles of poorly water-soluble active pharmaceutical ingredients (APIs) to achieve improved active content uniformity and very fast dissolution from poorly water soluble actives, while accomplishing fast drying during the fabrication process.

Abstract: A microfluidic device comprising independently addressable arrays of interdigitated electrodes can be used to assembly and transport large-scale microparticle structures. The device and method uses collective phenomena in a negatively polarized suspension exposed to a high-gradient strong ac electric field to assemble the particles into predetermined locations and then transport them collectively to a work area for final assembly by sequentially energizing the electrode arrays.

Abstract: An anti-solvent fluid technique is provided that assists in the formation, production and manufacture of fine particles including micro-sized and nanometer-sized particles for a wide variety of bio-medical and pharmaceutical applications. This technique is particularly effective for the manufacturing of polymers/biopolymers/drugs of micron, submicron or nano size as well as particle coating/encapsulation. Co-solvents are used to dissolve the polymer or mixture of polymers to make a solution. The method facilitates rapid drying of precipitated particles with reduced size and agglomerations.